The oncoprotein Ski acts as an antagonist of transforming growth factor-β signaling by suppressing Smad2 phosphorylation

52Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The phosphorylation of Smad2 and Smad3 by the transforming growth factor (TGF)-β-activated receptor kinases and their subsequent heterodimerization with Smad4 and translocation to the nucleus form the basis for a model how Smad proteins work to transmit TGF-β signals. The transcriptional activity of Smad2-Smad4 or Smad3-Smad4 complexes can be limited by the corepressor Ski, which is believed to interact with Smad complexes on TGF-β-responsive promoters and represses their ability to activate TGF-β target genes by assembling on DNA a repressor complex containing histone deacetylase. Here we show that Ski can block TGF-β signaling by interfering with the phosphorylation of Smad2 and Smad3 by the activated TGF-β type I receptor. Furthermore, we demonstrate that overexpression of Ski induces the assembly of Smad2-Smad4 and Smad3-Smad4 complexes independent of TGF-β signaling. The ability of Ski to engage Smad proteins in nonproductive complexes provides new insights into the molecular mechanism used by Ski for disabling TGF-β signaling.

Cite

CITATION STYLE

APA

Prunier, C., Pessah, M., Ferrand, N., Ryeon Seo, S., How, P., & Atfi, A. (2003). The oncoprotein Ski acts as an antagonist of transforming growth factor-β signaling by suppressing Smad2 phosphorylation. Journal of Biological Chemistry, 278(28), 26249–26257. https://doi.org/10.1074/jbc.M304459200

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free